Premium
Patient‐reported control of chronic rhinosinusitis symptoms is positively associated with general health‐related quality of life
Author(s) -
Gray S.T.,
Hoehle L.P.,
Phillips K.M.,
Caradonna D.S.,
Sedaghat A.R.
Publication year - 2017
Publication title -
clinical otolaryngology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.914
H-Index - 68
eISSN - 1749-4486
pISSN - 1749-4478
DOI - 10.1111/coa.12841
Subject(s) - medicine , quality of life (healthcare) , visual analogue scale , chronic rhinosinusitis , eq 5d , cohort , prospective cohort study , cohort study , cross sectional study , young adult , health related quality of life , physical therapy , disease , pathology , nursing
Objective In chronic rhinosinusitis ( CRS ), although patient‐reported severity of sinonasal symptoms is significantly associated with diminishment of patients’ general health‐related quality of life ( QOL ), it remains unclear whether patient‐perceived control of CRS symptomatology is associated with patients’ QOL . In this study, we sought to determine the association between patient‐perceived control of CRS symptomatology and QOL . Design Prospective cross‐sectional study. Setting Academic, tertiary care centre. Participants A cohort of 166 adults with CRS who were asked to categorise their level of CRS symptom control as “Not at all,” “A little,” “Somewhat,” “Very” and “Completely.” Main outcome measure General health‐related QOL , as reflected by the five‐dimensional EuroQol quality of life survey‐derived visual analogue scale ( EQ 5D‐ VAS ) and health utility values ( EQ 5D‐ HUV ). Results We found that higher EQ 5D‐ VAS scores were associated with CRS patients who classified their symptom control as “Very” (adjusted β=15.74, 95% CI : 5.44 to 26.04, P =.003) and “Completely” (adjusted β=14.24, 95% CI : 2.98 to 25.52, P =.014) compared to patients who classified their symptom control as “Not at all.” This was also true for higher EQ 5D‐ HUV which was associated with patient‐reported CRS symptom control of “A little” (adjusted β=0.10, 95% CI : 0.01 to 0.18, P =.024), “Somewhat” (adjusted β=0.08, 95% CI : 0.00 to 0.17, P =.049), “Very” (adjusted β=0.13, 95% CI : 0.05 to 0.21, P =.002) and “Completely” (adjusted β=0.18, 95% CI : 0.09 to 0.27, P <.001). Conclusions Higher levels of patient‐reported CRS symptom control are therefore associated with better QOL . These findings suggest that CRS symptom control should be targeted for improving patients’ QOL .